Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fusobacterium nucleatum Fap2 lectin, also known as Fibroblast activation protein 2, is a large (~390 kDa) outer membrane autotransporter protein that serves as a critical virulence factor for the bacterium (3.1.4, 3.4.1). It functions as a bifunctional adhesin, specifically recognizing and binding to the carbohydrate moiety Gal-GalNAc (D-galactose-β(1-3)-N-acetyl-D-galactosamine), which is overexpressed on the surface of colorectal cancer (CRC) cells and other adenocarcinomas (2.3.1, 2.3.3). This interaction facilitates the 'precision homing' and colonization of F. nucleatum in tumor tissues, where the bacterium promotes tumor progression, metastasis, and chemoresistance (2.3.4, 3.4.3). Additionally, Fap2 interacts with the inhibitory receptor TIGIT on natural killer (NK) cells and T lymphocytes, leading to the suppression of host anti-tumor immunity (2.1.1, 3.1.5). Due to its central role in bacterial recruitment to tumors and immune evasion, Fap2 is considered a promising therapeutic target for the treatment of F. nucleatum-associated cancers, with strategies including the development of inhibitory antibodies, small molecules, and vaccines (3.2.2, 3.3.1).
Fap2 mediates bacterial recruitment to tumors by binding to Gal-GalNAc on cancer cells and inhibits host anti-tumor immunity by activating the TIGIT receptor on NK and T cells (2.1.1, 2.3.1, 3.4.4).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fusobacterium nucleatum Fap2 lectin (Fap2).